GE HealthCare Technologies Inc. (GEHC) Fair Value 2026

GEHC · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.9 /10

32 fundamental signals · 11 models active

Value Trap Risk

SAFE (17/100)

Quick Summary — As of 2026-08-28, GE HealthCare Technologies Inc. (GEHC) trades at $71.72, versus a $55.25 median fair value across its 11 active models — 23.0% below the current price. QOC: 7.9/10. Value Trap Risk: 17/100 (SAFE). 11/13 models active. Within that set, the Bayesian DCF component alone returns $58.91.

Key Facts

Ticker
GEHC
Price
$71.72
Quality Score
7.9/10
Value Trap Risk
17/100
Models Active
11/13
Last Updated
Strength: 11 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is GE HealthCare Technologies Inc. (GEHC) Undervalued or Overvalued in 2026?

According to CirclFi’s 11-model valuation engine, GE HealthCare Technologies Inc. (GEHC) appears overvalued as of : the median of 11 independent fair value estimates is $55.25, 23.0% below the current price of $71.72. Estimates range from $7.49 to $163.08. GEHC scores 7.9/10 on fundamental quality and 17/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. GEHC’s -23.0% gap is narrower than that market norm, and the Medical Devices sector median is -43.7%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy GE HealthCare Technologies Inc. Stock in 2026? →

What Fair Value Does Each Model Give GEHC?

11 Intrinsic Value Models vs. Current Price ($71.72)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $58.91 -17.9%
Intrinsic · High Conviction
 $37.39 -47.9%
Ensemble · Low Conviction
 $53.62 -25.2%
Intrinsic · High Conviction
 $40.12 -44.1%
Unlock the Full Matrix

Access 7 additional models including Markov DDM, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 11 Models →

Cancel anytime · No contracts · Instant access

What Is GEHC's Fair Value Range?

Spread across 11 independent models · $7.49 to $163.08

CirclFi's 11 active models place GE HealthCare Technologies Inc. (GEHC) between $7.49 and $163.08 per share, a spread of 282% of the median. The median of that range — $55.25 — is the fair value CirclFi publishes for GEHC, against a current price of $71.72.

Low · Markov DDMHigh · Regime Cross
$7.49median $55.25$163.08
Where the range comes from
Most bearish modelMarkov DDM$7.49
Most bullish modelRegime Cross-Sectional$163.08
Model agreement2 bullish · 8 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for GEHC. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on GEHC, not a CirclFi price target. How each model works →

What Is GE HealthCare Technologies Inc. (GEHC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on GE HealthCare Technologies Inc. at its current price of $71.73. The median intrinsic value is estimated at $55.25 (-23.0% vs price), with 8 models flagging overvaluation risk. The most optimistic model, Regime Cross, places fair value at $163.08 (+127.4%), while Markov DDM — the most conservative — estimates $7.49 (-89.6%). This +216.9% gap reflects genuine analytical uncertainty about GE HealthCare Technologies Inc.'s intrinsic worth. Among models with highest confidence, Bayesian DCF, EPV, EROIC lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About GEHC?

11 of 13 models are currently active for GEHC. Of these, 2 models suggest upside while 9 models suggest overvaluation. Taken together, their median fair value for GEHC is $55.25 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $58.91 on its own, implying -17.9% downside from the current price. See which stocks rank higher →

How Does GEHC Rank in Medical Devices?

Among 159 Medical Devices stocks, GEHC ranks #30 by Quality of Company score. CirclFi's QOC score of 7.9/10 evaluates 32 fundamental signals. A score of 7.9 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

Within the Medical Devices space, GE HealthCare Technologies Inc. competes in an environment where clinical trial success rate often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is GEHC a Value Trap?

CirclFi's Value Trap algorithm assigns GEHC a score of 17/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

11 of 13 models are active for GE HealthCare Technologies Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, GE HealthCare Technologies Inc. is rated at 7.9/10. This strong-tier score demonstrates strong fundamentals across the majority of our quality signals.

The gap between the most bullish and bearish model spans +216.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every GEHC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across GEHC's 11 active models, average confidence is 57%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy GE HealthCare Technologies Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

INFUInfuSystem Holdings, Inc.QOC 8.1MDTMedtronic plcQOC 7.8LIVNLivaNova PLCQOC 8.1BIOBio-Rad Laboratories, Inc.QOC 7.8VMDViemed Healthcare, Inc.QOC 8.2AXGNAxogen, Inc.QOC 7.6TMCITreace Medical Concepts, Inc.QOC 6.5PACBPacific Biosciences of California, Inc.QOC 5.6LUDGLudwig Enterprises, Inc.QOC 3.7IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: INFU · MDT · LIVN · BIO · VMD · AXGN · TMCI · PACB · LUDG · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to GEHC?

7 companies across all industries closest to GEHC’s Quality of Company score of 7.9/10.

CROXCrocs, Inc.QOC 7.9CCFNMuncy Columbia Financial CorporationQOC 7.9FRDFriedman Industries, IncorporatedQOC 7.9WMGWarner Music Group Corp.QOC 7.9DIODDiodes IncorporatedQOC 7.9BRXBrixmor Property Group Inc.QOC 7.9NVDANVIDIA CorporationQOC 10.0

Read investment analysis: CROX · CCFN · FRD · WMG · DIOD · BRX · NVDA

Where Does GEHC Sit in CirclFi's Medical Devices Rankings?

GEHC is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About GE HealthCare Technologies Inc.’s Valuation?

What is GE HealthCare Technologies Inc.'s intrinsic value in 2026?

CirclFi puts GE HealthCare Technologies Inc. (GEHC)'s intrinsic value at $55.25 — the median of 11 independent model estimates as of 2026-08-28, ranging from $7.49 to $163.08. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $58.91 on its own. The Quality of Company score is 7.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is GEHC overvalued or undervalued right now?

At $71.72, 2 of 11 active models suggest GEHC may be undervalued, while 9 indicate potential overvaluation. The median of all 11 fair value estimates is $55.25, 23.0% below the current price of $71.72 — a consensus view that GEHC is overvalued. The assessment depends on which methodology best fits GE HealthCare Technologies Inc.'s business model in Medical Devices.

What does a Quality of Company score of 7.9 mean for GEHC?

GE HealthCare Technologies Inc.'s QOC of 7.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on GEHC?

CirclFi analyzes GEHC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 11 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on GEHC?

Of the 11 models currently active on GEHC, Regime Cross-Sectional is the most bullish at $163.08 per share, and Markov DDM is the most bearish at $7.49. CirclFi's published fair value for GEHC is the median of that range, $55.25, not either extreme. The gap between the two ends equals 282% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is GEHC a value trap in 2026?

GE HealthCare Technologies Inc.'s Value Trap score is 17/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 11-model valuation engine, GE HealthCare Technologies Inc. (GEHC) has a median fair value of $55.25 — 23.0% below the current price of $71.72 — as of 2026-08-28.” Source: circlfi.com/stock/GEHC/ · Methodology
Primary sources for this GEHC valuation
  • Financial statements: GE HealthCare Technologies Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001932393) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for GEHC as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 11 mathematical frameworks give you clarity on GEHC.

Unlock All 11 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

7 models hidden for GEHC Unlock All 11 — $39/mo